Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Mark-Up By Senate Finance Delayed Until After Recess

Executive Summary

The Senate Finance Committee will not mark up Medicare reform legislation that would establish a prescription drug benefit until after the August congressional recess.
Advertisement

Related Content

PBMs Would Compete For Medicare Enrollees Under Sen. Roth's Rx Drug Plan
PBMs Would Compete For Medicare Enrollees Under Sen. Roth's Rx Drug Plan
PBMs Would Compete For Medicare Enrollees Under Sen. Roth's Rx Drug Plan
Roth Trades Stop-Loss For 80/20 Split: Appears Unattractive To Drug Industry
Roth Trades Stop-Loss For 80/20 Split: Appears Unattractive To Drug Industry
Advertisement
UsernamePublicRestriction

Register

PS036419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel